Mike McDermott, chief global supply officer and executive vice-president at the pharmaceutical giant, said the company had a very strong development pipeline for new products, which needed flexible facilities.
“Our pipeline is incredibly strong, and we need facilities that can accept that pipeline and are nimble ...
Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação: